Fiona Markwood has been appointed executive vice president of oncology project management at Novella Clinical. She is responsible for developing and guiding strategic direction for the oncology division and oversees all clinical projects and provides executive oversight.
 
Ms. Markwood has more than 24 years in the pharmaceutical industry, including operations management experience within clinical research at both large pharma and CROs. Most recently, she served as vice president of global strategic alliances and vice president of global project management for a large, global CRO.
 
Anusha Bala, BSc, LLB, was named global head of regulatory affairs at Novella Clinical. She oversees regulatory clinical research projects, safety reporting for oncology and medical device customers, and provides the project team with guidance, training and strategic planning. Ms. Bala has 16 years of regulatory affairs experience globally across numerous therapeutic areas including oncology, CNS and respiratory research.
 
Prior to joining Novella, Ms. Bala held senior regulatory affairs roles at a variety of organizations including the Medicines and Healthcare Products Regulatory Agency (MHRA), PRA Health Sciences and PAREXEL Consulting, part of PAREXEL International.
 
Joy Yucaitis has been named senior director of oncology strategy. Ms. Yucaitis provides therapeutic and development consulting to oncology customers, strategic planning for new protocols, and executive oversight for key projects. She also supports Novella’s global oncology operational and business development teams. Ms. Yucaitis has more than 18 years of oncology drug and diagnostic development experience as both a sponsor and CRO director.